Vimarsana
Biggest News Aggregation in the World

Page 27 - Libra Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Libra Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Libra Group Today - Breaking & Trending Today

Meet the Women Who Lead Dcode Capital, Connecting Startups, Government - Vimarsana News

Meet the Women Who Lead Dcode Capital, Connecting Startups, Government

Dcode This story is available exclusively to Insider subscribers. Become an Insider and start reading now. All four managing partners at Dcode Capital are women — a rarity in the world of venture capital. The four have expertise in connecting investors and startups with deep-pocketed government agencies. CEO Meagan Metzger says Dcode brings partners together in an atmosphere of 'psychological safety.' The four women who lead Dcode Capital, the investment arm of the Washington, DC, startup accelerator Dcode, pull together thre...

What Is Ban the Box? - business.com - Vimarsana News

What Is Ban the Box? - business.com

Product and service reviews are conducted independently by our editorial team, but we sometimes make money when you click on links.Learn more. What Employers Need to Know About Ban the Box Alison Grillo Jan 25, 2021 It is important to examine your company's policies for seeking information on criminal history of job candidates. Many states and cities have legislation on when this information can be requested. Landing a job can be a difficult process, and it's even harder for those who have a criminal history. For years, most job applications asked whether the candidate had ever been convicted...

Welldoc Submits 510(k) for Bolus and Premixed Insulin Titration Program as Part of BlueStar® - Vimarsana News

Welldoc Submits 510(k) for Bolus and Premixed Insulin Titration Program as Part of BlueStar®

Welldoc Submits 510(k) for Bolus and Premixed Insulin Titration Program as Part of BlueStar® Welldoc Submits 510(k) for Bolus and Premixed Insulin Titration Program as Part of BlueStar® Welldoc, a trailblazer in digital health that is revolutionizing chronic condition management to help transform lives, today announced the filing of its ninth 510(k) with the U.S. Food and Drug Administration (FDA) for BlueStar, an FDA-cleared digital health solution for diabetes. With the filing, BlueStar looks to add bolus and premixed insulin titration for type 2 diabetes to its comprehensive diabetes pl...